Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W CLARKE

Showing results (781-790 of 856) with videos related to

Pageof 86
Sort By:
European Urology Oncology|April 6, 2024
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel TrialFred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
The Lancet. Oncology|September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialFred Saad, Noel W Clarke, Mototsugu Oya, et al.
Scientific Reports|March 19, 2021
Time spent outdoors in childhood is associated with reduced risk of myopia as an adultGareth Lingham, Seyhan Yazar, Robyn M Lucas, et al.
BJU International|November 19, 2010
Early prostate cancer--which treatment do men prefer and why?Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
British Journal of Cancer|September 30, 2016
Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot studyS E T Larkin, H E Johnston, T R Jackson, et al.
JACC. Cardiooncology|November 16, 2023
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic ReviewAdam J Nelson, Renato D Lopes, Hwanhee Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysisC L Vale, D J Fisher, I R White, et al.
Nature|June 4, 2025
Acetolysis for epoxy-amine carbon fibre-reinforced polymer recyclingCiaran W Lahive, Stephen H Dempsey, Sydney E Reiber, et al.
European Urology Oncology|April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate CancerMarina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
ACS Sustainable Chemistry & Engineering|March 14, 2025
Tunable and Degradable Dynamic Thermosets from Compatibilized Polyhydroxyalkanoate BlendsChen Ling, Ryan W Clarke, Gloria Rosetto, et al.
Pageof 86

Showing results (781-790 of 856) with videos related to

Sort By:
Pageof 86
European Urology Oncology|April 6, 2024
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel TrialFred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
The Lancet. Oncology|September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialFred Saad, Noel W Clarke, Mototsugu Oya, et al.
Scientific Reports|March 19, 2021
Time spent outdoors in childhood is associated with reduced risk of myopia as an adultGareth Lingham, Seyhan Yazar, Robyn M Lucas, et al.
BJU International|November 19, 2010
Early prostate cancer--which treatment do men prefer and why?Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
British Journal of Cancer|September 30, 2016
Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot studyS E T Larkin, H E Johnston, T R Jackson, et al.
JACC. Cardiooncology|November 16, 2023
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic ReviewAdam J Nelson, Renato D Lopes, Hwanhee Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysisC L Vale, D J Fisher, I R White, et al.
Nature|June 4, 2025
Acetolysis for epoxy-amine carbon fibre-reinforced polymer recyclingCiaran W Lahive, Stephen H Dempsey, Sydney E Reiber, et al.
European Urology Oncology|April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate CancerMarina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
ACS Sustainable Chemistry & Engineering|March 14, 2025
Tunable and Degradable Dynamic Thermosets from Compatibilized Polyhydroxyalkanoate BlendsChen Ling, Ryan W Clarke, Gloria Rosetto, et al.
Pageof 86